Trends & Insights, January 2026: A pharmaphorum industry rep...
Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
Newsletters and Deep Dive digital magazine
Outside of the main headlines, our new Trends & Insights report looks at the wider breadth of life sciences industry news.
AI-powered drug developer Generate Biomedicine completes a $400m IPO, the largest for biotech on the Nasdaq so far this year.
Eisai has launched a 'digital destination', called Kompass, that aims to support patients after they have been given a diagnosis of kidney cancer.
AI scientists will no longer operate at the margins of life sciences research - they'll become essential collaborators in the labs of tomorrow.
As reported in January this year, the United States Centers for Medicare & Medicaid Services (CMS) rolled out $10 billion in
Editor's Picks
Newsletters and Deep Dive
digital magazine